DiaMedica Therapeutics Inc.
For the period ended May 20, 2026. Filed Apr 1, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 20, 2026 · Filed Apr 1, 2026
DMAC$9.36+3.5%Stored close · as of Nov 6, 2026
Contents
Effect of Proposal
In the event of a negative vote on this Proposal, our Audit Committee would reconsider its selection.
The Board of Directors unanimously recommends that shareholders voteFOR ratification of the appointment of Baker Tilly US, LLP, as our independent registered public accounting firm for the fiscal year ending December 31, 2026.
| The Board of Directors Unanimously Recommends a Vote FOR this Proposal Two | ☑ |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.